School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Department of Sports Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Molecules. 2020 Jul 8;25(14):3119. doi: 10.3390/molecules25143119.
Sesamin (SSM) is a water-insoluble compound that is easily eliminated by liver metabolism. To improve the solubility and bioavailability of SSM, this study developed and characterized a self-nanoemulsifying drug delivery system (SNEDDS) for the oral delivery of SSM and conducted pharmacokinetic assessments. Oil and surfactant materials suitable for SNEDDS preparation were selected on the basis of their saturation solubility at 37 ± 0.5 °C. The mixing ratios of excipients were determined on the basis of their dispersibility, transmittance (%), droplet sizes, and polydispersity index. An SNEDDS (F10) formulation comprising glyceryl trioctanoate, polyoxyethylene castor oil, and Tween 20 at a ratio of 10:10:80 (//) was the optimal formulation. This formulation maintained over 90% of its contents in different storage environments for 12 weeks. After the self-emulsification of SNEDDS, the SSM dispersed droplet size was 66.4 ± 31.4 nm, intestinal permeability increased by more than three-fold, relative bioavailability increased by approximately 12.9-fold, and absolute bioavailability increased from 0.3% to 4.4%. Accordingly, the developed SNEDDS formulation can preserve SSM's solubility, permeability, and bioavailability. Therefore, this SNEDDS formulation has great potential for the oral administration of SSM, which can enhance its pharmacological application value.
芝麻素(SSM)是一种水溶性差的化合物,很容易被肝脏代谢消除。为了提高 SSM 的溶解度和生物利用度,本研究开发并表征了一种用于 SSM 口服给药的自微乳给药系统(SNEDDS),并进行了药代动力学评估。根据 37±0.5°C 时的饱和溶解度选择适合 SNEDDS 制备的油和表面活性剂材料。根据辅料的分散性、透光率(%)、粒径和多分散指数确定辅料的混合比。由甘油三辛酸酯、聚氧乙烯蓖麻油和吐温 20 以 10:10:80(//)的比例组成的 SNEDDS(F10)制剂是最佳制剂。该制剂在 12 周的不同储存环境下保持超过 90%的含量。在 SNEDDS 自乳化后,SSM 分散的液滴尺寸为 66.4±31.4nm,肠道通透性增加了三倍以上,相对生物利用度增加了约 12.9 倍,绝对生物利用度从 0.3%增加到 4.4%。因此,开发的 SNEDDS 制剂可以保持 SSM 的溶解度、渗透性和生物利用度。因此,这种 SNEDDS 制剂具有很大的潜力用于 SSM 的口服给药,可以提高其药理应用价值。